Petco Health And Wellness Company, Inc. · NASDAQ:WOOF
Petco Health And Wellness — Q3 2025 Earnings Presentation
17 slides from Petco Health And Wellness's earnings presentation, Nov 25, 2025
Slide 1: Third Quarter 2025 Earnings Call
Third Quarter 2025 Earnings Call November 25, 2025
Slide 2: Safe Harbor and Non-GAAP Measures
Safe Harbor and Non-GAAP Measures This Presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amend
Slide 3: Third Quarter Key Takeaways
Third Quarter Key Takeaways Continued execution on 2025 profitability goals ➢ Operating income increased ~$25M ➢ Adj. EBITDA1 increased ~$17M ➢ Generated Free Cash Flow1 of ~$61M Setting foundation for healthier growth ahead ➢ With healthier base, Petco is poised to unlock value through defined grow
Slide 4: Executing Against Priorities in 2025
Q2 and Full Executing Year 2025 Against Guidance Priorities in 2025 Phase 1 – Strengthening Fundamentals • Strengthening retail fundamentals • Completed build out of senior leadership team with proven retail executives Phase 2 – Implementing and Executing • Continued progress on improving retail fun
Slide 5: Growth Drivers
Growth Drivers Four pillars supported by our strengthened economic model Compelling Product Trusted Store Experience A regular stream of product newness Passionate partners and strong complementing our evergreen customer engagement that fosters a assortment with fresh and trend- memorable and differ
Slide 6: Economic Model
Expand gross margin rate Leverage expenses through operational excellence & renewed Economic Model cost discipline Our number-one financial priority is clear: Improve ROIC by instilling new rigor and discipline into capital restoring the health of our economic model which, in turn, will improve our
Slide 7: Q3 2025 Net Sales & Comp
Q3 2025 Net Sales & Comp NET SALES BY CATEGORY Q3 Takeaways ($ in millions) $1,511 $1,552 $1,493 $1,489 $1,464 242 Net Sales Services and Other 248 252 263 255 ➢ Includes the impact of 25 net closures 510 529 in FY’24 and 9 net closures YTD’25 Supplies and CA 494 496 478 Services and Other ➢ Reflect
Slide 8: Q3 2025 Results
Q3 2025 Results OPERATING INCOME ADJUSTED EBITDA1 ($ in millions) ($ in millions) $99 $81 $29 $4 Q3'24 Q3'25 Q3'24 Q3'25 Operating Income 0.3% 2.0% Adj. EBITDA Margin1 5.4% 6.7% Margin NET DEBT1 & LIQUIDITY 2 FREE CASH FLOW1 ($ in millions) Q3’24 Q3’25 YoY % Change $71 $61 Net Debt1 $1.47B $1.36B (8
Slide 9: Q4 and Full Year 2025 Outlook
Q4 and Full Year 2025 Outlook Q4 2025 Outlook2 Net sales Down low single digits y/y Adjusted EBITDA1 $93M to $95M Full Year 2025 Outlook2 Current Prior (as of 8/28/25) Net sales Down 2.5% - 2.8% Down low single digits y/y Adjusted EBITDA1 $395M to $397M $385M to $395M Net interest expense ~$125M ~$1
Slide 10: Non-GAAP Measures and Other Definitions
Non-GAAP Measure and Other Definitions
Slide 11: Non-GAAP Measures and Other Definitions
Non-GAAP Measures and Other Definitions The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this Presentation to the most directly comparable financial measures calculated and presented in accordance with U.S. generally accepted accounti
Slide 12: Non-GAAP Measures: Adjusted EBITDA
Non-GAAP Measures: Adjusted EBITDA* * Please see slide at the end of this Presentation for related footnotes. 12
Slide 13: Non-GAAP Measures: Free Cash Flow
Non-GAAP Measures: Free Cash Flow 13
Slide 14: Non-GAAP Measures: Net Debt
Non-GAAP Measures: Net Debt 14
Slide 15: Net Sales by Category
Net Sales by Category eer 13 Weeks Ended November 1, November 2, October 28, % Change % Change 2025 2024 2023 (1 yr) (2 yr) Consumables $ 731,456 $ 753,230 $ 733,277 (3%) (0%) Supplies and companion animals 478,145 509,964 524,526 (6%) (9%) Services and other 254,810 248,243 236,363 3% 8% Net sales
Slide 16: Non-GAAP Financial Measures' Footnotes
Non-GAAP Financial Measures’ Footnotes (1) Mexico Joint Venture EBITDA represents 50 percent of the entity’s operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity m
Slide 17: Thank You
Thank You ©2025 Petco Health and Wellness Company, Inc.
Petco Health and Wellness Company — Q3 2025 Earnings Presentation on 6ix